NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase
In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial
Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher
ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust
Clinton Seeks Cut In NIH Increase
Advisory Council To Be Named For Alternative Medicine Cuts
James Shannon, 89, Led NIH In 1960’s Period of Growth
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line









